Published in Blood on January 31, 2008
InterLymph hierarchical classification of lymphoid neoplasms for epidemiologic research based on the WHO classification (2008): update and future directions. Blood (2010) 2.21
Population-based study of autoimmune conditions and the risk of specific lymphoid malignancies. Int J Cancer (2009) 2.01
Increased risk of monoclonal gammopathy in first-degree relatives of patients with multiple myeloma or monoclonal gammopathy of undetermined significance. Blood (2009) 1.90
Disease associations with monoclonal gammopathy of undetermined significance: a population-based study of 17,398 patients. Mayo Clin Proc (2009) 1.88
Elevated IL-17 produced by TH17 cells promotes myeloma cell growth and inhibits immune function in multiple myeloma. Blood (2010) 1.79
Hematopoietic malignancies associated with viral and alcoholic hepatitis. Cancer Epidemiol Biomarkers Prev (2008) 1.59
Multiple associations between a broad spectrum of autoimmune diseases, chronic inflammatory diseases and cancer. Anticancer Res (2012) 1.53
Second malignancies after multiple myeloma: from 1960s to 2010s. Blood (2012) 1.46
Autoimmunity and lymphomagenesis. Int J Cancer (2009) 1.29
Immune-related and inflammatory conditions and risk of lymphoplasmacytic lymphoma or Waldenstrom macroglobulinemia. J Natl Cancer Inst (2010) 1.24
Race and outcomes of autologous hematopoietic cell transplantation for multiple myeloma. Biol Blood Marrow Transplant (2009) 1.14
Genetic and immune-related factors in the pathogenesis of lymphoproliferative and plasma cell malignancies. Haematologica (2009) 1.03
Disparities in the prevalence, pathogenesis and progression of monoclonal gammopathy of undetermined significance and multiple myeloma between blacks and whites. Leukemia (2011) 1.03
Effect of autoimmune diseases on incidence and survival in subsequent multiple myeloma. J Hematol Oncol (2012) 0.97
Monoclonal gammopathy of undetermined significance and risk of infections: a population-based study. Haematologica (2011) 0.94
Racial disparities in the prevalence of monoclonal gammopathies: a population-based study of 12,482 persons from the National Health and Nutritional Examination Survey. Leukemia (2014) 0.88
Personal and family history of immune-related conditions increase the risk of plasma cell disorders: a population-based study. Blood (2011) 0.86
Immune-related conditions and subsequent risk of brain cancer in a cohort of 4.5 million male US veterans. Br J Cancer (2014) 0.86
Unusual case of simultaneous presentation of plasma cell myeloma, chronic myelogenous leukemia, and a jak2 positive myeloproliferative disorder. Case Rep Hematol (2014) 0.83
Herpes zoster is associated with an increased risk of subsequent lymphoid malignancies - a nationwide population-based matched-control study in Taiwan. BMC Cancer (2012) 0.83
Discovering the meaning of monoclonal gammopathy of undetermined significance: current knowledge, future challenges. Transl Med UniSa (2014) 0.82
Differential characteristics of Waldenström macroglobulinemia according to patterns of familial aggregation. Blood (2010) 0.82
Characterization of the Toll-like receptor expression profile in human multiple myeloma cells. PLoS One (2013) 0.81
Neoplastic and non-neoplastic complications of solid organ transplantation in patients with preexisting monoclonal gammopathy of undetermined significance. Clin Transplant (2015) 0.79
Associations between allergies and risk of hematologic malignancies: results from the VITamins and lifestyle cohort study. Am J Hematol (2013) 0.79
Hepatocellular carcinoma and other malignancies in autoimmune hepatitis. Dig Dis Sci (2013) 0.79
Risk of malignancy in ankylosing spondylitis: a systematic review and meta-analysis. Sci Rep (2016) 0.78
The relationship between hypogammaglobulinemia, monoclonal gammopathy of undetermined significance and humoral immunodeficiency: a case series. J Clin Immunol (2011) 0.78
Myelin protein zero is naturally processed in the B cells of monoclonal gammopathy of undetermined significance of immunoglobulin M isotype: aberrant triggering of a patient's T cells. Haematologica (2009) 0.78
Common infection-related conditions and risk of lymphoid malignancies in older individuals. Br J Cancer (2014) 0.78
Systemic Sclerosis and Malignancy: A Review of Current Data. J Clin Med Res (2016) 0.78
Family history of hematologic malignancies and risk of multiple myeloma: differences by race and clinical features. Cancer Causes Control (2015) 0.77
Ascites as the presenting symptom of multiple myeloma in a scleroderma patient. Case Rep Rheumatol (2014) 0.76
Risk of multiple myeloma in rheumatoid arthritis: a meta-analysis of case-control and cohort studies. PLoS One (2014) 0.76
Autoimmune manifestations in patients with multiple myeloma and monoclonal gammopathy of undetermined significance. BBA Clin (2016) 0.75
High prevalence of polyclonal hypergamma-globulinemia in adult males in Ghana, Africa. Am J Hematol (2011) 0.75
Common community-acquired infections and subsequent risk of multiple myeloma: a population-based study. Int J Cancer (2013) 0.75
Oligo-secretory myeloma in a patient with ankylosing spondylitis. Rheumatol Int (2009) 0.75
Association between cancer and allergies. Allergy Asthma Clin Immunol (2016) 0.75
Aspergillus fumigatus scleritis associated with monoclonal gammopathy of undetermined significance. Korean J Ophthalmol (2010) 0.75
Herpes Zoster and Risk of Cancer in the Elderly U.S. Population. Cancer Epidemiol Biomarkers Prev (2015) 0.75
The Diagnosis and Treatment of Multiple Myeloma. Dtsch Arztebl Int (2016) 0.75
History of autoimmune disease is associated with impaired survival in multiple myeloma and monoclonal gammopathy of undetermined significance: a population-based study. Ann Hematol (2016) 0.75
Are epidemiological data on lymphoma incidence comparable? Results from an application of the coding recommendations of WHO, InterLymph, ENCR and SEER to a cancer registry dataset. J Cancer Res Clin Oncol (2015) 0.75
Cancer statistics, 2007. CA Cancer J Clin (2007) 53.49
Statistical methods in cancer research. Volume II--The design and analysis of cohort studies. IARC Sci Publ (1987) 27.11
Multiple myeloma. N Engl J Med (2004) 10.81
Understanding multiple myeloma pathogenesis in the bone marrow to identify new therapeutic targets. Nat Rev Cancer (2007) 5.57
Risk of monoclonal gammopathy of undetermined significance (MGUS) and subsequent multiple myeloma among African American and white veterans in the United States. Blood (2005) 3.25
Risk of malignancy among patients with rheumatic conditions. Int J Cancer (2000) 2.70
Risk of non-Hodgkin lymphoma and lymphoproliferative precursor diseases in US veterans with hepatitis C virus. JAMA (2007) 2.51
Proliferative glomerulonephritis with monoclonal IgG deposits: a distinct entity mimicking immune-complex glomerulonephritis. Kidney Int (2004) 2.39
Monoclonal gammopathy of undetermined significance, Waldenström macroglobulinemia, AL amyloidosis, and related plasma cell disorders: diagnosis and treatment. Mayo Clin Proc (2006) 1.87
Diagnosis and management of acute low back pain. Am Fam Physician (2000) 1.77
Pernicious anemia and subsequent cancer. A population-based cohort study. Cancer (1993) 1.75
US Department of Veterans Affairs medical care system as a resource to epidemiologists. Am J Epidemiol (2000) 1.71
Hepatitis C virus and risk of lymphoma and other lymphoid neoplasms: a meta-analysis of epidemiologic studies. Cancer Epidemiol Biomarkers Prev (2006) 1.69
Cancer mortality following X-ray treatment for ankylosing spondylitis. Int J Cancer (1994) 1.66
Familial characteristics of autoimmune and hematologic disorders in 8,406 multiple myeloma patients: a population-based case-control study. Int J Cancer (2006) 1.61
Differences in patient characteristics between Veterans Administration and community hospitals. Implications for VA planning. Med Care (1987) 1.60
Prevalence of vitamin B12 deficiency in patients with plasma cell dyscrasias: a retrospective review. Cancer (2004) 1.53
Signalling and survival pathways in multiple myeloma. Eur J Cancer (2006) 1.52
Cancer risk following pernicious anaemia. Br J Cancer (1989) 1.50
Rheumatoid arthritis and cancer studies based on linking nationwide registries in Finland. Am J Med (1985) 1.29
A case-control study of multiple myeloma nested in the American Cancer Society prospective study. Int J Cancer (1989) 1.28
Haematopoietic cancer and medical history: a multicentre case control study. J Epidemiol Community Health (2000) 1.27
MGUS and smoldering multiple myeloma: update on pathogenesis, natural history, and management. Hematology Am Soc Hematol Educ Program (2005) 1.23
Allergies and agricultural exposure as risk factors for multiple myeloma. Br J Cancer (1983) 1.20
Leukemia, lymphoma, and multiple myeloma following selected medical conditions. Cancer Causes Control (1992) 1.15
Risk of multiple myeloma following medication use and medical conditions: a case-control study in Connecticut women. Cancer Epidemiol Biomarkers Prev (2006) 1.13
A case-control study of multiple myeloma in whites: chronic antigenic stimulation, occupation, and drug use. Cancer Res (1987) 1.11
Occurrence of malignant neoplasms in the Rochester, Minnesota, rheumatoid arthritis cohort. Am J Med (1985) 1.10
Respiratory tract infections in the pathway to multiple myeloma: a population-based study in Scandinavia. Haematologica (2006) 1.07
Multiple myeloma presented as acute interstitial nephritis and rheumatoid arthritis-like polyarthritis. Am J Hematol (2007) 1.05
Allergic conditions and risk of hematological malignancies in adults: a cohort study. BMC Public Health (2004) 1.04
Antigenic stimulation and the occurrence of multiple myeloma. Am J Epidemiol (1987) 1.01
Risks of cancer among a cohort of 23,935 men and women with osteoporosis. Int J Cancer (2008) 1.00
Multiple myeloma among blacks and whites in the United States: the role of chronic antigenic stimulation. Cancer Causes Control (1994) 0.96
Medical history and the risk of multiple myeloma. Br J Cancer (1991) 0.94
Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma. Blood Rev (2007) 0.94
Arthritis associated with monoclonal gammapathy: clinical characteristics. Br J Rheumatol (1996) 0.92
Autoimmune disorders and multiple myeloma. Int J Epidemiol (1989) 0.88
Rheumatoid arthritis as a risk factor for multiple myeloma: a case-control study. Eur J Cancer (1993) 0.88
Hepatitis C virus infection in patients with essential mixed cryoglobulinemia, multiple myeloma and chronic lymphocytic leukemia. Pathol Oncol Res (2001) 0.87
Multiple myeloma following an episode of community-acquired pneumococcal bacteraemia or meningitis. APMIS (2001) 0.85
Ankylosing spondylitis and monoclonal gammopathies. Ann Rheum Dis (1992) 0.84
Ankylosing spondylitis associated with IgA lambda chain myeloma. Br J Rheumatol (1997) 0.83
Hematopoietic and lymphoproliferative cancer among male veterans using the Veterans Administration Medical System. Cancer (1991) 0.83
Monoclonal gammopathy in chronic active hepatitis. Liver (1984) 0.81
Pneumococcemia as the presenting feature of multiple myeloma. Am J Hematol (2004) 0.80
Rapidly progressive glomerulonephritis and monoclonal gammopathy. Am J Med (1985) 0.79
Association of ankylosing spondylitis with IgA-multiple myeloma: report of a case and pathogenetic considerations. Taiwan Yi Xue Hui Za Zhi (1989) 0.79
Paraproteinaemias: pathophysiology. Schweiz Med Wochenschr (2000) 0.79
Patterns of survival in multiple myeloma: a population-based study of patients diagnosed in Sweden from 1973 to 2003. J Clin Oncol (2007) 3.32
Risk of monoclonal gammopathy of undetermined significance (MGUS) and subsequent multiple myeloma among African American and white veterans in the United States. Blood (2005) 3.25
Plasmacytoma of bone, extramedullary plasmacytoma, and multiple myeloma: incidence and survival in the United States, 1992-2004. Br J Haematol (2008) 3.21
Risk of cancer after blood transfusion from donors with subclinical cancer: a retrospective cohort study. Lancet (2007) 3.00
Cancer incidence in a population-based cohort of individuals hospitalized with celiac disease or dermatitis herpetiformis. Gastroenterology (2002) 2.94
Relation of body mass index to cancer risk in 362,552 Swedish men. Cancer Causes Control (2006) 2.64
Solid cancers after allogeneic hematopoietic cell transplantation. Blood (2008) 2.56
Risk of acute myeloid leukemia and myelodysplastic syndromes after multiple myeloma and its precursor disease (MGUS). Blood (2011) 2.54
Risk of non-Hodgkin lymphoma and lymphoproliferative precursor diseases in US veterans with hepatitis C virus. JAMA (2007) 2.51
Obesity and cancer risk among white and black United States veterans. Cancer Causes Control (2004) 2.36
Success story of targeted therapy in chronic myeloid leukemia: a population-based study of patients diagnosed in Sweden from 1973 to 2008. J Clin Oncol (2011) 2.34
Risk of cancer in a large cohort of U.S. veterans with diabetes. Int J Cancer (2011) 2.23
Ascertainment and diagnostic accuracy for hematopoietic lymphoproliferative malignancies in Sweden 1964-2003. Int J Cancer (2007) 2.16
Racial disparities in incidence and outcome in multiple myeloma: a population-based study. Blood (2010) 2.12
Chronic immune stimulation might act as a trigger for the development of acute myeloid leukemia or myelodysplastic syndromes. J Clin Oncol (2011) 2.11
Control of autophagic cell death by caspase-10 in multiple myeloma. Cancer Cell (2013) 2.06
Chronic lymphocytic leukaemia: an overview of aetiology in light of recent developments in classification and pathogenesis. Br J Haematol (2007) 2.02
Free light chains and the risk of AIDS-defining opportunistic infections in HIV-infected individuals. Clin Infect Dis (2012) 2.01
Population-based study of autoimmune conditions and the risk of specific lymphoid malignancies. Int J Cancer (2009) 2.01
Autoimmunity and susceptibility to Hodgkin lymphoma: a population-based case-control study in Scandinavia. J Natl Cancer Inst (2006) 1.90
Arterial and venous thrombosis in monoclonal gammopathy of undetermined significance and multiple myeloma: a population-based study. Blood (2010) 1.89
Causes of death in patients with celiac disease in a population-based Swedish cohort. Arch Intern Med (2003) 1.88
Patterns of improved survival in patients with multiple myeloma in the twenty-first century: a population-based study. J Clin Oncol (2009) 1.88
Risk of hepatobiliary and pancreatic cancers after hepatitis C virus infection: A population-based study of U.S. veterans. Hepatology (2009) 1.80
Deep vein thrombosis after monoclonal gammopathy of undetermined significance and multiple myeloma. Blood (2008) 1.78
Minimal residual disease: what are the minimum requirements? J Clin Oncol (2014) 1.76
Cancer in Korean war navy technicians: mortality survey after 40 years. Am J Epidemiol (2002) 1.66
Tubal sterilization and risk of ovarian, endometrial and cervical cancer. A Danish population-based follow-up study of more than 65 000 sterilized women. Int J Epidemiol (2004) 1.66
Monoclonal gammopathy of undetermined significance and risk of lymphoid and myeloid malignancies: 728 cases followed up to 30 years in Sweden. Blood (2013) 1.64
Improved patient survival for acute myeloid leukemia: a population-based study of 9729 patients diagnosed in Sweden between 1973 and 2005. Blood (2008) 1.61
Familial characteristics of autoimmune and hematologic disorders in 8,406 multiple myeloma patients: a population-based case-control study. Int J Cancer (2006) 1.61
Familial aggregation of Hodgkin lymphoma and related tumors. Cancer (2004) 1.60
Hematopoietic malignancies associated with viral and alcoholic hepatitis. Cancer Epidemiol Biomarkers Prev (2008) 1.59
Risk of malignant disease among 1525 adult male US Veterans with Gaucher disease. Arch Intern Med (2007) 1.56
Chronic lymphocytic leukaemia and small lymphocytic lymphoma: overview of the descriptive epidemiology. Br J Haematol (2007) 1.54
International Myeloma Working Group consensus statement for the management, treatment, and supportive care of patients with myeloma not eligible for standard autologous stem-cell transplantation. J Clin Oncol (2014) 1.52
Treatment-related risk factors for transformation to acute myeloid leukemia and myelodysplastic syndromes in myeloproliferative neoplasms. J Clin Oncol (2011) 1.51
Concomitant and antecedent deep venous thrombosis and cancer survival in male US veterans. Leuk Lymphoma (2011) 1.50
Elevated risk of chronic lymphocytic leukemia and other indolent non-Hodgkin's lymphomas among relatives of patients with chronic lymphocytic leukemia. Haematologica (2009) 1.50
Autoimmune disease in individuals and close family members and susceptibility to non-Hodgkin's lymphoma. Arthritis Rheum (2008) 1.50
Immunologic and virologic predictors of AIDS-related non-hodgkin lymphoma in the highly active antiretroviral therapy era. J Acquir Immune Defic Syndr (2010) 1.47
Second malignancies after multiple myeloma: from 1960s to 2010s. Blood (2012) 1.46
Patterns of survival among patients with myeloproliferative neoplasms diagnosed in Sweden from 1973 to 2008: a population-based study. J Clin Oncol (2012) 1.46
Familial aggregation and heterogeneity of non-Hodgkin lymphoma in population-based samples. Cancer Epidemiol Biomarkers Prev (2005) 1.45
Respiratory tract infections and subsequent risk of chronic lymphocytic leukemia. Blood (2006) 1.39
Borrelia and subsequent risk of solid tumors and hematologic malignancies in Sweden. Int J Cancer (2012) 1.39
Cancer risk among patients with myotonic muscular dystrophy. JAMA (2011) 1.38
Serum free light chains as predictors of lymphomagenesis in patients with autosomal dominant hyper-immunoglobulin E syndrome (Job's syndrome). Leuk Lymphoma (2012) 1.38
Immune-related conditions and immune-modulating medications as risk factors for non-Hodgkin's lymphoma: a case-control study. Am J Epidemiol (2005) 1.36
Increased risk for non-Hodgkin lymphoma in individuals with celiac disease and a potential familial association. Gastroenterology (2008) 1.36
Allium vegetables and risk of prostate cancer: a population-based study. J Natl Cancer Inst (2002) 1.32
Dietary factors and risk of colon cancer in Shanghai, China. Cancer Epidemiol Biomarkers Prev (2003) 1.31
Autoimmunity and lymphomagenesis. Int J Cancer (2009) 1.29
IMWG consensus on maintenance therapy in multiple myeloma. Blood (2012) 1.29
Autoimmune disease and subsequent risk of developing alimentary tract cancers among 4.5 million US male veterans. Cancer (2010) 1.25
Autoimmunity and the risk of myeloproliferative neoplasms. Haematologica (2010) 1.25
Immune-related and inflammatory conditions and risk of lymphoplasmacytic lymphoma or Waldenstrom macroglobulinemia. J Natl Cancer Inst (2010) 1.24
Improved survival in chronic lymphocytic leukemia in the past decade: a population-based study including 11,179 patients diagnosed between 1973-2003 in Sweden. Haematologica (2009) 1.21
Myeloma and second primary cancers. N Engl J Med (2011) 1.20
Patterns of survival and causes of death following a diagnosis of monoclonal gammopathy of undetermined significance: a population-based study. Haematologica (2009) 1.19
Highly increased familial risks for specific lymphoma subtypes. Br J Haematol (2009) 1.16
Patterns of autoimmunity and subsequent chronic lymphocytic leukemia in Nordic countries. Blood (2006) 1.16
Evidence of serum immunoglobulin abnormalities up to 9.8 years before diagnosis of chronic lymphocytic leukemia: a prospective study. Blood (2009) 1.15
Chronic immune stimulation and subsequent Waldenström macroglobulinemia. Arch Intern Med (2008) 1.14
Long-term risks after splenectomy among 8,149 cancer-free American veterans: a cohort study with up to 27 years follow-up. Haematologica (2013) 1.14
Prostate carcinoma risk subsequent to diagnosis of benign prostatic hyperplasia: a population-based cohort study in Sweden. Cancer (2003) 1.13
Acquired immune-related and inflammatory conditions and subsequent chronic lymphocytic leukaemia. Br J Haematol (2007) 1.12
Patterns of hematologic malignancies and solid tumors among 37,838 first-degree relatives of 13,896 patients with multiple myeloma in Sweden. Int J Cancer (2009) 1.12
Racial differences in chronic immune stimulatory conditions and risk of non-Hodgkin's lymphoma in veterans from the United States. J Clin Oncol (2010) 1.11
Etiologic factors for male breast cancer in the U.S. Veterans Affairs medical care system database. Breast Cancer Res Treat (2009) 1.10
Cancer incidence among pesticide applicators exposed to permethrin in the Agricultural Health Study. Environ Health Perspect (2008) 1.09
Monoclonal gammopathy of undetermined significance and risk of skeletal fractures: a population-based study. Blood (2010) 1.09
Alcohol concentration and risk of oral cancer in Puerto Rico. Am J Epidemiol (2003) 1.08
Mortality and cancer incidence among individuals with Down syndrome. Arch Intern Med (2003) 1.08
Risk of second malignant neoplasms among lymphoma patients with a family history of cancer. Int J Cancer (2007) 1.07
Respiratory tract infections in the pathway to multiple myeloma: a population-based study in Scandinavia. Haematologica (2006) 1.07
Polyclonal immunoglobulin free light chains as a potential biomarker of immune stimulation and inflammation. Clin Chem (2011) 1.06
Risk of immune thrombocytopenic purpura and autoimmune hemolytic anemia among 120 908 US veterans with hepatitis C virus infection. Arch Intern Med (2009) 1.06
Modeling progression risk for smoldering multiple myeloma: results from a prospective clinical study. Leuk Lymphoma (2013) 1.06
MYD88 L265P somatic mutation in IgM MGUS. N Engl J Med (2012) 1.06
Minimal residual disease testing in multiple myeloma by flow cytometry: major heterogeneity. Blood (2013) 1.06
Rapid increase in colorectal cancer rates in urban Shanghai, 1972-97, in relation to dietary changes. J Cancer Epidemiol Prev (2002) 1.05
Patterns of survival in lymphoplasmacytic lymphoma/Waldenström macroglobulinemia: a population-based study of 1,555 patients diagnosed in Sweden from 1980 to 2005. Am J Hematol (2012) 1.05
Common community acquired infections and subsequent risk of chronic lymphocytic leukaemia. Br J Haematol (2009) 1.04
Occupational physical activity and risk for cancer of the colon and rectum in Sweden among men and women by anatomic subsite. Eur J Cancer Prev (2008) 1.04
Genetic and immune-related factors in the pathogenesis of lymphoproliferative and plasma cell malignancies. Haematologica (2009) 1.03
Increased risk for lymphoid and myeloid neoplasms in elderly solid-organ transplant recipients. Cancer Epidemiol Biomarkers Prev (2010) 1.03